Company intelligence / Profile preview

Beijing Qingyuan Kaiwu Technology

Ownership: Private
Development stage: Commercial

Overview

Beijing Qingyuan Kaiwu Technology specializes in the development and production of high-end instruments supporting the upstream sector of life sciences and biomedicine. The company focuses on automation, intelligence, and industrial application of advanced technologies to enable innovation in biopharmaceutical research & development as well as in vitro diagnostics. It recently secured investment from the Beijing Pharmaceutical and Health Industry Investment Fund via private placement closed May 2024, indicating active operations with institutional backing.

Modalities: Instrumentation/automation platforms for biopharma and in vitro diagnostics
Industry: Drug Discovery Services

Partnerships

Beijing Pharmaceutical and Health Industry Investment Fund

Beyond the preview

Go deeper on Beijing Qingyuan Kaiwu Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Qingyuan Kaiwu Technology.

Explore the full profile